The 11th German Pharm-Tox Summit (GPTS 20 26) ↗ is a leading annual event bringing together researchers\, clinicians\, toxicologists\, pharmac ologists\, and regulatory experts to discuss cutting-edge developments in pharmacology and toxicology. The scientific programme features sessions co vering experimental and clinical pharmacology\, novel toxicology models\, mechanistic insights into adverse outcomes\, integrated safety testing str ategies\, and translational approaches for regulatory science. The Summit also offers dedicated opportunities for early-career scientists to present their work and expand professional networks\, as well as interactive disc ussions that bridge fundamental science with real-world safety and health applications. \;
In a special session\, presided over by Philip Marx-Stoelting and Jacob van Klaveren\, recent advances in PARC will be pr esented. \;
PARC will also be represented by: \;
These presentations will highlight PARC’s contributions to impro ving mechanistic understanding and in vitro modelling for liver-relevant t oxicological assessment. PARC encourages its community to attend and activ ely engage in this important scientific dialogue. \;
For r egistration\, programme details\, and further information\, please visit t he official GPTS 2026 website ↗.
X-MICROSOFT-CDO-ALLDAYEVENT:TRUE DTSTAMP:20260613T074759Z END:VEVENT BEGIN:VEVENT UID:6a2d0b2f6ce8a DTSTART;VALUE=DATE:20260318 SEQUENCE:0 TRANSP:OPAQUE DTEND;VALUE=DATE:20260319 SUMMARY:Advances in Pharmacology and Toxicology: German Summit 2026 CLASS:PUBLIC DESCRIPTION:The 11th German Pharm-Tox Summit (GPTS 2026) ↗ is a leading a nnual event bringing together researchers\, clinicians\, toxicologists\, p harmacologists\, and regulatory experts to discuss cutting-edge developmen ts in pharmacology and toxicology. The scientific programme features sessi ons covering experimental and clinical pharmacology\, novel toxicology mod els\, mechanistic insights into adverse outcomes\, integrated safety testi ng strategies\, and translational approaches for regulatory science. The S ummit also offers dedicated opportunities for early-career scientists to p resent their work and expand professional networks\, as well as interactiv e discussions that bridge fundamental science with real-world safety and h ealth applications. \;In a special session\, presided over by Philip M arx-Stoelting and Jacob van Klaveren\, recent advances in PARC will be pre sented. \;PARC will also be represented by: \;Neele Wewer ↗ (Ger man Federal Institute for Risk Assessment) ↗ with two communications: “Combined Effects of Steatosis- and Phospholipidosis-Inducing Compounds on Lipid and Xenobiotic Metabolism in Human Liver Cells” and “Characte risation and Applicability of an In Vitro Liver Model Coculturing Four Dif ferent Cell Types in 3D”.Indigo Brakus ↗ (German Federal Institute for Risk Assessment) ↗: \"Establishing a zebrafish neurosphere assay in vit ro culture for DNT testing.\"Ilka Scharkin ↗ (IUF – Leibniz Research I nstitute for Environmental Medicine ↗): \"Advancing Next-Generation Neur otoxicity Testing with human 3D-BrainSpheres - One platform for different exposure scenarios across developmental stages\".Lars Dahmen ↗ (German F ederal Institute for Risk Assessment) ↗: \"Primary Thyroid Follicles fro m Pigs as a New Approach Methodology to Improve in vitro Testing Strategie s for Thyroid Hormone System Disruptors\". \; \; \;Bil Wiene ke (National Institute for Public Health and the Environment ↗\, Nether lands): \"Mixture risk assessment\". \;These presentations will highl ight PARC’s contributions to improving mechanistic understanding and in vitro modelling for liver-relevant toxicological assessment. PARC encourag es its community to attend and actively engage in this important scientifi c dialogue. \;For registration\, programme details\, and further infor mation\, please visit the official GPTS 2026 website ↗. X-ALT-DESC;FMTTYPE=text/html:The 11th German Pharm-Tox Summit (GPTS 20 26) ↗ is a leading annual event bringing together researchers\, clinicians\, toxicologists\, pharmac ologists\, and regulatory experts to discuss cutting-edge developments in pharmacology and toxicology. The scientific programme features sessions co vering experimental and clinical pharmacology\, novel toxicology models\, mechanistic insights into adverse outcomes\, integrated safety testing str ategies\, and translational approaches for regulatory science. The Summit also offers dedicated opportunities for early-career scientists to present their work and expand professional networks\, as well as interactive disc ussions that bridge fundamental science with real-world safety and health applications. \;
In a special session\, presided over by Philip Marx-Stoelting and Jacob van Klaveren\, recent advances in PARC will be pr esented. \;
PARC will also be represented by: \;
These presentations will highlight PARC’s contributions to impro ving mechanistic understanding and in vitro modelling for liver-relevant t oxicological assessment. PARC encourages its community to attend and activ ely engage in this important scientific dialogue. \;
For r egistration\, programme details\, and further information\, please visit t he official GPTS 2026 website ↗.
X-MICROSOFT-CDO-ALLDAYEVENT:TRUE DTSTAMP:20260613T074759Z END:VEVENT BEGIN:VEVENT UID:6a2d0b2f6ce9f DTSTART;VALUE=DATE:20260319 SEQUENCE:0 TRANSP:OPAQUE DTEND;VALUE=DATE:20260320 SUMMARY:Advances in Pharmacology and Toxicology: German Summit 2026 CLASS:PUBLIC DESCRIPTION:The 11th German Pharm-Tox Summit (GPTS 2026) ↗ is a leading a nnual event bringing together researchers\, clinicians\, toxicologists\, p harmacologists\, and regulatory experts to discuss cutting-edge developmen ts in pharmacology and toxicology. The scientific programme features sessi ons covering experimental and clinical pharmacology\, novel toxicology mod els\, mechanistic insights into adverse outcomes\, integrated safety testi ng strategies\, and translational approaches for regulatory science. The S ummit also offers dedicated opportunities for early-career scientists to p resent their work and expand professional networks\, as well as interactiv e discussions that bridge fundamental science with real-world safety and h ealth applications. \;In a special session\, presided over by Philip M arx-Stoelting and Jacob van Klaveren\, recent advances in PARC will be pre sented. \;PARC will also be represented by: \;Neele Wewer ↗ (Ger man Federal Institute for Risk Assessment) ↗ with two communications: “Combined Effects of Steatosis- and Phospholipidosis-Inducing Compounds on Lipid and Xenobiotic Metabolism in Human Liver Cells” and “Characte risation and Applicability of an In Vitro Liver Model Coculturing Four Dif ferent Cell Types in 3D”.Indigo Brakus ↗ (German Federal Institute for Risk Assessment) ↗: \"Establishing a zebrafish neurosphere assay in vit ro culture for DNT testing.\"Ilka Scharkin ↗ (IUF – Leibniz Research I nstitute for Environmental Medicine ↗): \"Advancing Next-Generation Neur otoxicity Testing with human 3D-BrainSpheres - One platform for different exposure scenarios across developmental stages\".Lars Dahmen ↗ (German F ederal Institute for Risk Assessment) ↗: \"Primary Thyroid Follicles fro m Pigs as a New Approach Methodology to Improve in vitro Testing Strategie s for Thyroid Hormone System Disruptors\". \; \; \;Bil Wiene ke (National Institute for Public Health and the Environment ↗\, Nether lands): \"Mixture risk assessment\". \;These presentations will highl ight PARC’s contributions to improving mechanistic understanding and in vitro modelling for liver-relevant toxicological assessment. PARC encourag es its community to attend and actively engage in this important scientifi c dialogue. \;For registration\, programme details\, and further infor mation\, please visit the official GPTS 2026 website ↗. X-ALT-DESC;FMTTYPE=text/html:The 11th German Pharm-Tox Summit (GPTS 20 26) ↗ is a leading annual event bringing together researchers\, clinicians\, toxicologists\, pharmac ologists\, and regulatory experts to discuss cutting-edge developments in pharmacology and toxicology. The scientific programme features sessions co vering experimental and clinical pharmacology\, novel toxicology models\, mechanistic insights into adverse outcomes\, integrated safety testing str ategies\, and translational approaches for regulatory science. The Summit also offers dedicated opportunities for early-career scientists to present their work and expand professional networks\, as well as interactive disc ussions that bridge fundamental science with real-world safety and health applications. \;
In a special session\, presided over by Philip Marx-Stoelting and Jacob van Klaveren\, recent advances in PARC will be pr esented. \;
PARC will also be represented by: \;
These presentations will highlight PARC’s contributions to impro ving mechanistic understanding and in vitro modelling for liver-relevant t oxicological assessment. PARC encourages its community to attend and activ ely engage in this important scientific dialogue. \;
For r egistration\, programme details\, and further information\, please visit t he official GPTS 2026 website ↗.
X-MICROSOFT-CDO-ALLDAYEVENT:TRUE DTSTAMP:20260613T074759Z END:VEVENT BEGIN:VEVENT UID:6a2d0b2f6ceb0 DTSTART;VALUE=DATE:20260320 SEQUENCE:0 TRANSP:OPAQUE DTEND;VALUE=DATE:20260321 SUMMARY:Advances in Pharmacology and Toxicology: German Summit 2026 CLASS:PUBLIC DESCRIPTION:The 11th German Pharm-Tox Summit (GPTS 2026) ↗ is a leading a nnual event bringing together researchers\, clinicians\, toxicologists\, p harmacologists\, and regulatory experts to discuss cutting-edge developmen ts in pharmacology and toxicology. The scientific programme features sessi ons covering experimental and clinical pharmacology\, novel toxicology mod els\, mechanistic insights into adverse outcomes\, integrated safety testi ng strategies\, and translational approaches for regulatory science. The S ummit also offers dedicated opportunities for early-career scientists to p resent their work and expand professional networks\, as well as interactiv e discussions that bridge fundamental science with real-world safety and h ealth applications. \;In a special session\, presided over by Philip M arx-Stoelting and Jacob van Klaveren\, recent advances in PARC will be pre sented. \;PARC will also be represented by: \;Neele Wewer ↗ (Ger man Federal Institute for Risk Assessment) ↗ with two communications: “Combined Effects of Steatosis- and Phospholipidosis-Inducing Compounds on Lipid and Xenobiotic Metabolism in Human Liver Cells” and “Characte risation and Applicability of an In Vitro Liver Model Coculturing Four Dif ferent Cell Types in 3D”.Indigo Brakus ↗ (German Federal Institute for Risk Assessment) ↗: \"Establishing a zebrafish neurosphere assay in vit ro culture for DNT testing.\"Ilka Scharkin ↗ (IUF – Leibniz Research I nstitute for Environmental Medicine ↗): \"Advancing Next-Generation Neur otoxicity Testing with human 3D-BrainSpheres - One platform for different exposure scenarios across developmental stages\".Lars Dahmen ↗ (German F ederal Institute for Risk Assessment) ↗: \"Primary Thyroid Follicles fro m Pigs as a New Approach Methodology to Improve in vitro Testing Strategie s for Thyroid Hormone System Disruptors\". \; \; \;Bil Wiene ke (National Institute for Public Health and the Environment ↗\, Nether lands): \"Mixture risk assessment\". \;These presentations will highl ight PARC’s contributions to improving mechanistic understanding and in vitro modelling for liver-relevant toxicological assessment. PARC encourag es its community to attend and actively engage in this important scientifi c dialogue. \;For registration\, programme details\, and further infor mation\, please visit the official GPTS 2026 website ↗. X-ALT-DESC;FMTTYPE=text/html:The 11th German Pharm-Tox Summit (GPTS 20 26) ↗ is a leading annual event bringing together researchers\, clinicians\, toxicologists\, pharmac ologists\, and regulatory experts to discuss cutting-edge developments in pharmacology and toxicology. The scientific programme features sessions co vering experimental and clinical pharmacology\, novel toxicology models\, mechanistic insights into adverse outcomes\, integrated safety testing str ategies\, and translational approaches for regulatory science. The Summit also offers dedicated opportunities for early-career scientists to present their work and expand professional networks\, as well as interactive disc ussions that bridge fundamental science with real-world safety and health applications. \;
In a special session\, presided over by Philip Marx-Stoelting and Jacob van Klaveren\, recent advances in PARC will be pr esented. \;
PARC will also be represented by: \;
These presentations will highlight PARC’s contributions to impro ving mechanistic understanding and in vitro modelling for liver-relevant t oxicological assessment. PARC encourages its community to attend and activ ely engage in this important scientific dialogue. \;
For r egistration\, programme details\, and further information\, please visit t he official GPTS 2026 website ↗.
X-MICROSOFT-CDO-ALLDAYEVENT:TRUE DTSTAMP:20260613T074759Z END:VEVENT END:VCALENDAR